Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Department of Emergency Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
J Clin Endocrinol Metab. 2018 Jun 1;103(6):2175-2181. doi: 10.1210/jc.2017-02437.
The homeostatic model assessment of insulin resistance (HOMA-IR) and triglyceride (TG)/high-density lipoprotein cholesterol (HDL-C) ratio (TG/HDL-C) are insulin resistance indexes routinely used in clinical and population-based studies; however, their short-term repeatability is not well characterized.
To quantify the short-term repeatability of insulin resistance indexes and their analytes, consisting of fasting glucose and insulin for HOMA-IR and TG and HDL-C for TG/HDL-C.
Prospective cohort study.
A total of 102 adults 68 to 88 years old without diabetes attended an initial examination and repeated examination (mean, 46 days; range, 28 to 102 days). Blood samples were collected, processed, shipped, and assayed following a standardized protocol.
Repeatability was quantified using the intraclass correlation coefficient (ICC) and within-person coefficient of variation (CV). Minimum detectable change (MDC95) and minimum detectable difference with 95% confidence (MDD95) were quantified.
For HOMA-IR, insulin, and fasting glucose, the ICCs were 0.70, 0.68, and 0.70, respectively; their respective within-person CVs were 30.4%, 28.8%, and 5.6%. For TG/HDL-C, TG, and HDL-C, the ICCs were 0.80, 0.68, and 0.91, respectively; their respective within-person CVs were 23.0%, 20.6%, and 8.2%. The MDC95 was 2.3 for HOMA-IR and 1.4 for TG/HDL-C. The MDD95 for a sample of n = 100 was 0.8 for HOMA-IR and 0.6 for TG/HDL-C.
Short-term repeatability was fair to good for HOMA-IR and excellent for TG/HDL-C according to suggested benchmarks, reflecting the short-term variability of their analytes. These measurement properties can inform the use of these indexes in clinical and population-based studies.
胰岛素抵抗的稳态模型评估(HOMA-IR)和三酰甘油(TG)/高密度脂蛋白胆固醇(HDL-C)比值(TG/HDL-C)是临床和基于人群研究中常用的胰岛素抵抗指标;然而,它们的短期重复性尚未得到很好的描述。
定量评估胰岛素抵抗指标及其分析物(HOMA-IR 的空腹血糖和胰岛素,以及 TG/HDL-C 的 TG 和 HDL-C)的短期重复性。
前瞻性队列研究。
共 102 名年龄在 68 至 88 岁之间、无糖尿病的成年人参加了初次检查和重复检查(平均 46 天;范围 28 至 102 天)。按照标准化方案采集、处理、运输和检测血样。
使用组内相关系数(ICC)和个体内变异系数(CV)来量化重复性。量化了最小可检测变化(MDC95)和 95%置信区间的最小可检测差值(MDD95)。
对于 HOMA-IR、胰岛素和空腹血糖,ICC 分别为 0.70、0.68 和 0.70;相应的个体内 CV 分别为 30.4%、28.8%和 5.6%。对于 TG/HDL-C、TG 和 HDL-C,ICC 分别为 0.80、0.68 和 0.91;相应的个体内 CV 分别为 23.0%、20.6%和 8.2%。MDC95 为 2.3 的 HOMA-IR 和 1.4 的 TG/HDL-C。对于 n=100 的样本,MDD95 为 0.8 的 HOMA-IR 和 0.6 的 TG/HDL-C。
根据建议的基准,HOMA-IR 的短期重复性为中等至良好,而 TG/HDL-C 的短期重复性为极好,反映了其分析物的短期变异性。这些测量特性可以为这些指标在临床和基于人群的研究中的应用提供信息。